115 related articles for article (PubMed ID: 6807178)
1. The structure and binding characteristics of serum amyloid protein (9.5S alpha 1-glycoprotein).
Painter RH; De Escallón I; Massey A; Pinteric L; Stern SB
Ann N Y Acad Sci; 1982; 389():199-215. PubMed ID: 6807178
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component.
de Beer FC; Baltz ML; Holford S; Feinstein A; Pepys MB
J Exp Med; 1981 Oct; 154(4):1134-9. PubMed ID: 6793685
[TBL] [Abstract][Full Text] [Related]
3. Human serum amyloid P component is a single uncomplexed pentamer in whole serum.
Hutchinson WL; Hohenester E; Pepys MB
Mol Med; 2000 Jun; 6(6):482-93. PubMed ID: 10972085
[TBL] [Abstract][Full Text] [Related]
4. Calcium-enhanced aggregation of serum amyloid P component and its inhibition by the ligands heparin and heparan sulphate. An electron microscopic and immunoelectrophoretic study.
Nielsen EH; Sørensen IJ; Vilsgaard K; Andersen O; Svehag SE
APMIS; 1994 Jun; 102(6):420-6. PubMed ID: 8068301
[TBL] [Abstract][Full Text] [Related]
5. Amino terminal sequence of amyloid P-component isolated from serum.
Benson MD; Skinner M
J Lab Clin Med; 1978 Jul; 92(1):78-83. PubMed ID: 96197
[TBL] [Abstract][Full Text] [Related]
6. Evidence that serum amyloid P component binds to mannose-terminated sequences of polysaccharides and glycoproteins.
Kubak BM; Potempa LA; Anderson B; Mahklouf S; Venegas M; Gewurz H; Gewurz AT
Mol Immunol; 1988 Sep; 25(9):851-8. PubMed ID: 3211159
[TBL] [Abstract][Full Text] [Related]
7. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose.
Hind CR; Collins PM; Renn D; Cook RB; Caspi D; Baltz ML; Pepys MB
J Exp Med; 1984 Apr; 159(4):1058-69. PubMed ID: 6707579
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of SAP and CRP, two pentraxins from Pangasianodon (Pangasius) hypophthalmus.
Huong Giang DT; Van Driessche E; Vandenberghe I; Devreese B; Beeckmans S
Fish Shellfish Immunol; 2010; 28(5-6):743-53. PubMed ID: 20109557
[TBL] [Abstract][Full Text] [Related]
9. Calcium-dependent aggregation of human serum amyloid P component.
Baltz ML; De Beer FC; Feinstein A; Pepys MB
Biochim Biophys Acta; 1982 Feb; 701(2):229-36. PubMed ID: 7074110
[TBL] [Abstract][Full Text] [Related]
10. Identification of multiple forms of the P component of amyloid isolated from human serum.
Kubak BM; Gewurz H; Potempa LA
Int Arch Allergy Appl Immunol; 1988; 87(2):194-203. PubMed ID: 3192306
[TBL] [Abstract][Full Text] [Related]
11. Amyloid P component binds to keratin bodies in human skin and to isolated keratin filament aggregates in vitro.
Hintner H; Booker J; Ashworth J; Auböck J; Pepys MB; Breathnach SM
J Invest Dermatol; 1988 Jul; 91(1):22-8. PubMed ID: 2455001
[TBL] [Abstract][Full Text] [Related]
12. Binding characteristics of human serum amyloid P component.
Serban D; Rordorf-Adam C
Scand J Immunol; 1987 Mar; 25(3):275-81. PubMed ID: 3105045
[TBL] [Abstract][Full Text] [Related]
13. A protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins.
Kinoshita CM; Gewurz AT; Siegel JN; Ying SC; Hugli TE; Coe JE; Gupta RK; Huckman R; Gewurz H
Protein Sci; 1992 Jun; 1(6):700-9. PubMed ID: 1304912
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of guinea-pig serum amyloid P component.
Maudsley S; Hind CR; Munn EA; Buttress N; Pepys MB
Immunology; 1986 Oct; 59(2):317-22. PubMed ID: 3770806
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of C-reactive protein and serum amyloid P component from bovine serum.
Morimatsu M; Sakai H; Yoshimatsu K; Minowa O; Yamamoto S; Yatomi K; Fujinaga T; Naiki M
Nihon Juigaku Zasshi; 1989 Aug; 51(4):723-32. PubMed ID: 2585927
[TBL] [Abstract][Full Text] [Related]
16. Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis.
Hawkins PN; Tennent GA; Woo P; Pepys MB
Clin Exp Immunol; 1991 May; 84(2):308-16. PubMed ID: 1673879
[TBL] [Abstract][Full Text] [Related]
17. A new pentraxin (serum amyloid P-component) in the rat: evidence for two quaternary structures and effect of ligands on self-association.
Pontet M; D'Asnieres M; Gache D; Escaig J; Engler R
Biochim Biophys Acta; 1981 Dec; 671(2):202-10. PubMed ID: 7326264
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.
Ozawa D; Nomura R; Mangione PP; Hasegawa K; Okoshi T; Porcari R; Bellotti V; Naiki H
Sci Rep; 2016 Jul; 6():29077. PubMed ID: 27380955
[TBL] [Abstract][Full Text] [Related]
19. Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses.
Ashton AW; Boehm MK; Gallimore JR; Pepys MB; Perkins SJ
J Mol Biol; 1997 Sep; 272(3):408-22. PubMed ID: 9325100
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.
de Beer FC; Baltz ML; Munn EA; Feinstein A; Taylor J; Bruton C; Clamp JR; Pepys MB
Immunology; 1982 Jan; 45(1):55-70. PubMed ID: 7056568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
